Cellbxhealth PLC
ANPCF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $38 | $30 | $106 | $275 |
| - Cash | $10 | $16 | $32 | $32 |
| + Debt | $4 | $5 | $5 | $2 |
| Enterprise Value | $32 | $19 | $79 | $246 |
| Revenue | $3 | $2 | $1 | $1 |
| % Growth | 30.9% | 110% | 2.8% | – |
| Gross Profit | $2 | -$0 | $1 | $1 |
| % Margin | 62.2% | -18.7% | 58.9% | 70.2% |
| EBITDA | -$13 | -$19 | -$24 | -$16 |
| % Margin | -455.1% | -869.1% | -2,342.7% | -1,551.7% |
| Net Income | -$14 | -$20 | -$22 | -$15 |
| % Margin | -497% | -921% | -2,083.2% | -1,481.9% |
| EPS Diluted | -0.048 | -0.077 | -0.088 | -0.067 |
| % Growth | 37.6% | 12.1% | -31.8% | – |
| Operating Cash Flow | -$13 | -$14 | -$16 | -$14 |
| Capital Expenditures | -$0 | -$1 | -$2 | -$2 |
| Free Cash Flow | -$14 | -$15 | -$18 | -$16 |